Philips Respironics has unveiled Alice NightOne, an at home sleep testing system (HST) desing to make testing easier for patients and providers.
As sleep therapy businesses try to keep pace with the demands of value-based care and changing reimbursement requirements, Alice NightOne enables the efficient identification and treatment of sleep disorder patients. Fully compatible with the Philips Somnolyzer scoring solution, sleep technicians can read the results from the Alice NightOne HST and determine a sleep study score in 50-85 percent less time and with great accuracy.
“Conventional laboratory-based sleep testing or polysomnography can pose challenges for sleep clinicians and patients, including limited availability and cost,” said Teofilo Lee-Chiong, M.D., chief medical liaison for Philips. “This latest, intuitive testing option allows reliable and accurate diagnosis of sleep disordered breathing that is more accessible and efficient. More importantly, it gives patients the option of having a sleep test in the comfort of their own home, which may improve overall patient experience and drive better outcomes.”
By eliminating the long wait times for an appointment and discomfort some patients associate with in-lab sleep studies, Alice NightOne can speed the time to diagnosis and treatment. With minimal sensors and intuitive icons, Alice NightOne helps patients set up their testing devices and limits discomfort while they sleep.
The testing platform includes Smart Guide technology that provides step-by-step instructions and feedback to ensure all functions are working properly, reducing the chance of patient error. The device indicates if additional testing may be required before the patient returns the equipment, further streamlining logistics.
Along with enabling sleep technicians to identify an appropriate score faster, Alice NightOne also provides the data necessary to differentiate between obstructive, central and positional sleep apnea.